Genscript Biotech (GNNSF) Q1 2026 Earnings

15MarConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.23
0.34
0.91
1.48

Details

Expected EPS
-0.03
Actual EPS
-0.23
Surprise EPS
-0.2
Surprise Percent
+666.67%

Description

Genscript Biotech (GNNSF) has reported earnings of -0.23 per share for Q1 2026.

0 Comments

Share your thoughts